Intestinal Microbiome Transplant in ALS

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions

Amyotrophic Lateral Sclerosis ALS

Interventions

DRUG

MTP-101C

MTP-101C is a freeze-dried encapsulated formulation of fecal microbiota purified from the stool of healthy donors.

Trial Locations (1)

Duke University Medical Center, Durham